Besins Hlthcare Drug Patent Portfolio
Besins Hlthcare owns 1 orange book drug protected by 15 US patents Given below is the list of Besins Hlthcare's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8446138 | Stability compensation circuit and DC-DC converter including the same | 12 Oct, 2026 | Active |
| US8466136 | Testosterone gel and method of use | 12 Oct, 2026 | Active |
| US8466137 | Testosterone gel and method of use | 12 Oct, 2026 | Active |
| US8466138 | Testosterone gel and method of use | 12 Oct, 2026 | Active |
| US8486925 | Testosterone gel and method of use | 12 Oct, 2026 | Active |
| US8729057 | Testosterone gel and method of use | 12 Oct, 2026 | Active |
| US8741881 | Testosterone gel and method of use | 12 Oct, 2026 | Active |
| US8754070 | Testosterone gel and method of use | 12 Oct, 2026 | Active |
| US8759329 | Testosterone gel and method of use | 12 Oct, 2026 | Active |
| US6503894 | Pharmaceutical composition and method for treating hypogonadism | 02 Mar, 2021 | Expired |
| US9125816 | Pharmaceutical composition and method for treating hypogonadism | 02 Mar, 2021 | Expired |
| US9132089 | Pharmaceutical composition and method for treating hypogonadism | 02 Mar, 2021 | Expired |
| US6503894 | Pharmaceutical composition and method for treating hypogonadism | 30 Aug, 2020 | Expired |
| US9125816 | Pharmaceutical composition and method for treating hypogonadism | 30 Aug, 2020 | Expired |
| US9132089 | Pharmaceutical composition and method for treating hypogonadism | 30 Aug, 2020 | Expired |
Latest Legal Activities on Besins Hlthcare's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Besins Hlthcare.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 23 Oct, 2023 | US9132089 (Litigated) |
|
Expire Patent
Critical
| 16 Oct, 2023 | US9125816 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 08 May, 2023 | US9132089 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 01 May, 2023 | US9125816 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 11 Nov, 2021 | US8741881 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 11 Nov, 2021 | US8759329 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 11 Nov, 2021 | US8754070 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 14 Oct, 2021 | US8729057 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Dec, 2020 | US8486925 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Sep, 2020 | US8466137 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Sep, 2020 | US8466138 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Sep, 2020 | US8466136 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 25 Sep, 2020 | US8446138 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2019 | US9125816 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2019 | US9132089 (Litigated) |
Besins Hlthcare Drug Patents' Oppositions Filed in EPO
Besins Hlthcare drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Aug 21, 2013, by Oser, Andreas. This opposition was filed on patent number EP06836341A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP06836341A | Aug, 2013 | Oser, Andreas | Opposition rejected |
Besins Hlthcare's Family Patents
Besins Hlthcare drugs have patent protection in a total of 29 countries. It's US patent count contributes only to 26.9% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Besins Hlthcare Drug List
Given below is the complete list of Besins Hlthcare's drugs and the patents protecting them.
1. Androgel
Androgel is protected by 16 patents, out of which 7 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8446138 | Stability compensation circuit and DC-DC converter including the same |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US8466136 | Testosterone gel and method of use |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US8466137 | Testosterone gel and method of use |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US8466138 | Testosterone gel and method of use |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US8486925 | Testosterone gel and method of use |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US8729057 | Testosterone gel and method of use |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US8741881 | Testosterone gel and method of use |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US8754070 | Testosterone gel and method of use |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US8759329 | Testosterone gel and method of use |
12 Oct, 2026
(1 year, 9 months from now)
| Active |
| US6503894
(Pediatric)
| Pharmaceutical composition and method for treating hypogonadism |
02 Mar, 2021
(3 years ago)
| Expired |
| US9125816
(Pediatric)
| Pharmaceutical composition and method for treating hypogonadism |
02 Mar, 2021
(3 years ago)
| Expired |
| US9132089
(Pediatric)
| Pharmaceutical composition and method for treating hypogonadism |
02 Mar, 2021
(3 years ago)
| Expired |
| US6503894
(Pediatric)
| Pharmaceutical composition and method for treating hypogonadism |
01 Mar, 2021
(3 years ago)
| Expired |
| US6503894 | Pharmaceutical composition and method for treating hypogonadism |
30 Aug, 2020
(4 years ago)
| Expired |
| US9125816 | Pharmaceutical composition and method for treating hypogonadism |
30 Aug, 2020
(4 years ago)
| Expired |
| US9132089 | Pharmaceutical composition and method for treating hypogonadism |
30 Aug, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Androgel's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List